NCT05857267View on ClinicalTrials.gov

Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 7, 2023

Primary Completion Date

November 4, 2024

Study Completion Date

November 4, 2024

Conditions
Glaucoma, Open-AngleOcular Hypertension
Interventions
DRUG

Dorzolamide / Timolol Ophthalmic Solution

Dorzolamide-timolol fixed combination in a preservative-free multidose device

DRUG

dorzolamide/timolol

Dorzolamide-timolol BAK-preserved fixed combination

Trial Locations (6)

B1636CSS

Clínica de Ojos Dr. Nano, Olivos

C1007ABK

Consultorio Dr. Peyret, Ciudad Autonoma de Buenos Aire

C1122AAK

Gonella Oftalmólogos, Ciudad Autonoma de Buenos Aire

C1425AYA

Centro Diagnóstico Dr. Gentile, Ciudad Autonoma de Buenos Aire

C1124

Centro oftalmológico Dr. Casiraghi & asociados, Ciudad Autónoma de Buenos Aire

C1425FAB

Consultorios de Oftalmología, Buenos Aires

Sponsors

Lead Sponsor

Laboratorios Poen
All Listed Sponsors
lead

Laboratorios Poen

INDUSTRY